| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Department of Pathology and Laboratory
Medicine,*
Curriculum in Toxicology, UNC Lineberger
Comprehensive Cancer Center, University of North Carolina School of
Medicine, Chapel Hill, North Carolina; and the Department of Medical
Oncology,
Rhode Island Hospital, Brown
University, Providence, Rhode Island
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Adult rodent livers contain at least two well-recognized cell populations with major stem-like properties, unipotential (committed) progenitor cells (fully differentiated hepatocytes and biliary epithelial cells), and multipotential nonparenchymal epithelial (ductular) progenitor cells, both of which can contribute to liver repair under different pathophysiological circumstances, although neither cell type proliferates to any significant extent under normal circumstances.9 Replacement of hepatocytes (and liver tissue mass) lost to surgical resection (partial hepatectomy) or toxic injury (necrosis) is typically achieved through the proliferation of fully differentiated, normally quiescent hepatocytes and biliary epithelial cells con-tained in the residual (viable) tissue.10-13 Adult rodent hepatocytes, for example, possess extensive growth potential14-16 and can proliferate through at least 86 cell doublings in vivo under experimental circumstances.17 Thus, fully differentiated hepatocytes exhibit essential properties ascribed to the stem cells of classic stem cell-fed lineage systems,7,9 including the ability to proliferate repeatedly and produce large numbers of differentiated progeny, and can be viewed as a unipotential progenitor cell for the generation of additional hepatocytes.9 Multipotential epithelial stem-like (oval) cells are not activated during liver repair in rodents if the mature residual hepatocytes and biliary epithelial cells are capable of proliferating to restore the normal liver mass and structure.18,19 However, after certain forms of toxic hepatocellular injury which impair the replicative capacity of hepatocytes, the liver parenchyma may be replaced from oval cells.7,8 In the current study, we provide evidence that a third liver progenitor cell with some stem-like properties, small incompletely differentiated hepatocyte-like cells, also may participate in liver tissue repair in rats. We have examined the cellular responses and time course for liver regeneration in rats with retrorsine-induced hepatocellular injury. Retrorsine is a member of the pyrrolizidine alkaloid (PA) family of naturally occurring compounds that are toxic to various mammalian tissues, including liver, lung, kidney, brain, muscle, heart, thymus, lymph nodes, and blood vessels.20-25 The hepatotoxic effects of PAs are long-lasting26-28 and include inhibition of hepatocyte cell division coupled with induction of polyploidy and megalocytosis.27,28 The acute development of megalocytosis in the livers of retrorsine-exposed rats results from the antimitotic action of the PA and its metabolites on hepatocytes that are stimulated to divide, such as is induced by partial hepatectomy (PH) or hepatocellular necrosis.29 In this model, neither retrorsine-injured, fully differentiated hepatocytes nor oval cells proliferate abundantly to contribute significantly to the restoration of liver mass after PH. Instead, the entire liver mass is reconstituted after PH through a novel cellular response that is mediated by the emergence and rapid expansion of a population of small hepatocyte-like progenitor cells, which share some phenotypic traits with fetal hepatoblasts, oval cells, and fully differentiated hepatocytes, but are morphologically and/or phenotypically distinct from each. Small hepatocyte-like cells emerge early following PH, proliferate rapidly to form expanding cellular aggregates that replace megalocytic hepatocytes, and concurrently acquire the panoply of differentiated features typical of mature hepatocytes. Replacement of lost hepatocytes and complete hepatic regeneration from the progeny of small hepatocyte-like progenitor cells have not been observed in other models of liver injury in which replication of residual mature hepatocytes is impaired, suggesting a novel mechanism for liver regeneration, mediated by the expansion of a previously uncharacterized liver progenitor cell type of the adult rat liver.
| Materials and Methods |
|---|
|
|
|---|
Male German-strain Fischer 344 DPPIV-deficient rats were used in these studies. The rats were bred and maintained in a colony at the University of North Carolina at Chapel Hill. The original breeders were obtained from the Department of Medical Oncology, Rhode Island Hospital, Brown University (Providence, RI).
Retrorsine Administration and PH
Male 6-week-old littermate Fischer 344 rats (approximately 100 g body weight) were randomized into retrorsine treatment (n = 72) and vehicle-treated control (n = 39) groups at the outset of the experiment. Rats in these groups received two treatments of retrorsine (30 mg/kg i.p.) or vehicle (equal volume of 150 mmol/L saline solution) 2 weeks apart, at 6 and 8 weeks of age. The retrorsine working solution was prepared as described.28 Retrorsine (12,18-dihydroxysenecionan-11,16-dione; ß-Longilobine, Sigma, St. Louis, MO) was added to distilled water at 10 mg/ml and titrated to pH 2.5 with 1 N HCl to completely dissolve the solid. Subsequently, the solution was neutralized using 1 N NaOH, and NaCl was added for a final concentration of 6 mg/ml retrorsine and 150 mmol/L NaCl, pH 7.0. The working solution was used immediately after preparation. Five weeks after the second retrorsine or vehicle treatment, experimental and control rats were randomized into the following groups: control (n = 5), control/PH (n = 34), retrorsine only (n = 15), and retrorsine/PH (n = 57). The control and retrorsine-only groups were not surgically manipulated. There was no mortality associated with vehicle or retrorsine treatment in the absence of PH. Surgical PH was performed essentially as originally described.30 Mortality rates after PH were higher in retrorsine-exposed rats (35%) than controls (18%), likely due to effects of retrorsine toxicity. Surviving rats in the retrorsine/PH (n = 37) and control/PH (n = 28) groups were euthanized and livers harvested at 1, 3, 5, 7, 10, 14, 17, 23, and 30 days after PH (n = 36 per time point). Likewise, rats in the retrorsine-only treatment group were euthanized and livers harvested at days 0, 7, 14, 21, and 30 after PH (n = 3 per time point) where day 0 represents 5 weeks after the final retrorsine treatment. The livers of unmanipulated control rats were collected concurrent with the 30-day post-PH time point (n = 5). At each endpoint, rat body weight and liver weight were recorded. Liver tissue was fixed in 10% neutral buffered formalin and processed routinely for paraffin-embedded sections. In addition, tissue was frozen and cryosections were prepared. Studies involving animals were carried out in accordance with federal and state guidelines put forth by the National Institutes of Health and the Institutional Animal Care and Use Committee of the University of North Carolina at Chapel Hill.
Histology
Formalin-fixed, paraffin-embedded liver tissue was sectioned at 6 µm and stained with hematoxylin and eosin (H&E) according to standard procedures. Cellular polysaccharide deposits were detected routinely using the periodic acid-Schiff (PAS) reaction. Verification of glycogen as a major component of cellular polysaccharides was accomplished by pretreatment of tissue sections with salivary amylase.
Enzyme Histochemistry
Bile canalicular ATPase was detected as described.31 Briefly, 6-µm liver cryosections were incubated for 30 minutes at 37°C in a substrate solution containing 0.5 mg/ml ATP (sodium salt), 10 mmol/L MgSO4, 3.63 mmol/L lead (II) nitrate, and 80 mmol/L Tris-maleate buffer, pH 7.2. ATPase activity was visualized by incubating the sections in a 0.22% solution of ammonium sulfide at room temperature (r.t.) for 3 minutes. Tissue sections were counterstained with methyl green and mounted in glycerol.
Immunohistochemical Detection of Hepatocyte, Bile Duct, and Oval Cell Markers
Hepatocyte markers were identified using mouse monoclonal antibody
H.4,32,33
rabbit anti-rat transferrin antibodies (Cappel,
Aurora, OH), and rabbit anti-rat albumin antibodies (Cappel). Bile duct
markers were detected using mouse monoclonal antibodies (mAbs)
BD.1,34
BD.2,35
and GST-
(Dako,
Carpinteria, CA). Oval cell markers were detected using mAbs
OV6,36
OC.2,32,33
OC.4, OC.5, and OC.10
(Hixson DC, unpublished). Immunostaining of transferrin and albumin was
performed on 6-µm paraffin sections. Other immunostaining reactions
were performed on 6-µm liver cryosections. Indirect immunoperoxidase
analysis was performed on paraffin sections that were cleared with
xylene and passed through a graded series of alcohols ending with a
short incubation (15 minutes) in PBS (136 mmol/L NaCl, 2.7 mmol/L KCl,
10 mmol/L Na2HPO4, and 1.76
mmol/L KH2PO4, pH 7.2) at
r.t. to fully rehydrate tissue sections. Detection of primary
antibodies was accomplished using the avidin/biotin peroxidase system
(Vectastain rabbit kit, Vector, Burlingame, CA). Endogenous peroxidase
activity was quenched using 0.3%
H2O2 in PBS for 10 minutes
at r.t. Blocking of nonspecific activity was accomplished by incubation
in buffer containing serum of the secondary antibody species for 30
minutes at r.t. Polyclonal antibodies to transferrin and albumin were
diluted 1:200 in PBS, incubated on tissue sections for 30 minutes, and
detected using diaminobenzidine (DAB kit, Vector) with Gills
hematoxylin counterstain. Indirect immunofluorescence analysis was
performed on cryosections fixed in cold acetone (-20°C, 10 minutes).
Blocking of nonspecific activity was accomplished by incubation in 1%
normal goat serum in PBS for 30 minutes at r.t. Primary antibodies were
diluted at 1:100 (OV6 at 1:2000, GST-
at 1:25) in PBS/1% normal
goat serum and incubated with tissue sections for 30 minutes at r.t.
The FITC-conjugated polyvalent secondary antibody (Sigma) was diluted
to 1:100 in PBS/1% normal goat serum. Incubation with secondary
antibody was done at 4°C for 30 minutes. Sections were counterstained
with propidium iodide. Images were captured using a Nikon FXA
microscope and color transparency film.
Estimation of the Proliferative Cell Fraction after PH
The nuclear antigen Ki-67 was used as a marker of dividing cells37 and is present in proliferating cells exclusively. Indirect immunoperoxidase analysis was performed using 6-µm paraffin sections that were cleared with xylene, passed through a graded series of alcohols, and incubated for 15 minutes in TBS (25 mmol/L Tris-Cl, 136 mmol/L NaCl, and 27 mmol/L KCl, pH 7.2) at r.t. to fully rehydrate tissue sections. Antigen retrieval was accomplished by microwaving (~750 watts) slides in antigen retrieval buffer (1.8 mmol/L citric acid, 8.2 mmol/L sodium citrate in deionized water) for a total of four 5-minute cycles, then cooled in TBS at r.t. Endogenous peroxidase activity was quenched using 0.3% H2O2 in TBS for 10 minutes. Cells in the growth cycle were decorated with a mouse monoclonal antibody to Ki-67 antigen (Immunotech, Marseille, France) at a dilution of 1:50 in TBS. Detection was accomplished using the avidin/biotin peroxidase system (Vectastain kit, Vector), developed in True Blue peroxidase substrate (Kirkegaard & Perry, Gaithersburg, MD), and counterstained with contrast red.
Characterization of Retrorsine-Induced Inflammation after PH
To assess the inflammatory response observed in H&E-stained sections in retrorsine/PH rats, indirect immunoperoxidase analysis was performed on 6-µm paraffin sections from retrorsine-exposed and control rats at 1 and 3 days post-PH using mouse monoclonal antibodies to rat ED1 (monocytes and tissue macrophages) and ED2 (tissue macrophages alone), as described38 with minor modifications. Monoclonal antibodies to rat ED1 and ED2 were purchased from Serotec (Kidlington, Oxford, UK). Paraffin sections were cleared with xylene and rehydrated through a graded series of alcohols. To inactivate endogenous peroxidase, sections were incubated at r.t. for 15 minutes in a 0.5% solution of H2O2 in PBS. To block nonspecific staining, sections were incubated at r.t. for 10 minutes in 20% normal rabbit serum/PBS. Primary antibodies were diluted in normal rabbit serum/PBS (ED1 1:100, ED2 1:10) and incubated on sections for 45 minutes at 4°C. The secondary antibody, peroxidase conjugated rabbit anti-mouse immunoglobulin (Dako), was diluted 1:20 in normal rabbit serum/PBS and incubated on sections for 30 minutes at r.t. Antibodies were detected using diaminobenzidine (DAB kit, Vector) with Gills hematoxylin counterstain.
Morphometric Analysis
Computerized morphometry was used to quantify the area of parenchyma occupied by clusters of small hepatocytes in regenerating liver of retrorsine/PH rats at various times after PH and to estimate the size of hepatocytes, megalocytes, and small hepatocyte-like progenitor cells in control and retrorsine-exposed rat livers. This analysis was performed using a Macintosh G3 computer and NIH Image software (http://rsb.info.nih.gov/nih-image/). For area quantification, two random H&E-stained sections were chosen for analysis from three different rats per time point after PH (3, 7, 14, and 30 days). Small hepatocyte area was expressed as a percentage of the total liver section area averaged over six sections per time point. For cell size estimation, one random H&E-stained section was chosen for analysis from two different rats from each of the unmanipulated control rats, control/PH rats (at 3 days post-PH), and retrorsine/PH rats (at 3 days post-PH). Cell size was expressed (in units of µm2) as the average of 15 different random measurements per group.
Ultrastructure
Formalin-fixed tissue was immersed in 3% glutaraldehyde in a 100 mmol/L sodium cacodylate buffer, pH 7.4, with 0.05% CaCl2 overnight. Thin sections were postfixed in osmium tetroxide, stained with uranyl acetate and lead citrate, and examined using transmission electron microscopy.
Statistical Analysis
A two-tailed unpaired t-test was used to generate P values and determine the significance of all quantified differences in liver weights and liver/body weight ratios between experimental and control groups. GraphPad Prism software (v. 2.01) was used for all calculations.
| Results |
|---|
|
|
|---|
At 1 day post-PH, rats in the retrorsine/PH group have pale, friable livers that normalize in gross appearance by 5 days post-PH. Between 1 and 3 days post-PH, there is microscopic evidence of inflammation, mild coagulative necrosis, and hepatocyte apoptosis (data not shown). The inflammatory infiltrate at 1 day post-PH consists mainly of ED1-positive blood monocytes and ED2-positive Kupffer cells that increase in number by 3 days post-PH, possibly via local proliferation and continued recruitment to the liver. H&E-stained liver sections at 5 days post-PH show minimal evidence of continued inflammation. The livers of rats in the control and control/PH groups display normal color and texture at all time points, and demonstrate no indication of inflammation in H&E-stained sections. The livers of rats in the retrorsine-only group exhibit a mild inflammatory response that is confined to infrequent areas of localized necrosis. Verification of the lack of a generalized inflammatory response in these livers is demonstrated by ED1/ED2 immunohistochemistry (data not shown).
At 1 day post-PH in retrorsine/PH rats, residual hepatocytes already
show megalocytosis coupled with DNA synthesis and apoptotic bodies are
frequent. Easily identifiable small hepatocytes appear as isolated
clusters of 3 to 6 cells at 3 days post-PH (Figure 1A)
and are never colocalized with oval
cells. At this time point emerging clusters of small hepatocyte-like
progenitor cells are observed in 16% (range, 1025%) of liver
lobules. Examination of H&E-stained liver sections from multiple rats
show that emerging clusters of small hepatocyte-like cells are not
confined to periportal areas, as are emerging oval cells, and are found
in all lobular zones. Assessment of the sublobular localization of
expanding clusters of small hepatocyte-like progenitor cells reveals
that 31% are found in the periportal region, 43% are mid-lobular, and
26% are pericentrally located (n = 126 clusters
counted on ten random H&E-stained liver sections from four rats). Small
hepatocyte-like cells proliferate to form lobule-sized aggregates by 7
days post-PH (Figure 1C)
, coalesce into large patches by 10 days
post-PH (Figure 1E)
, and occupy nearly 50% of the area of the
parenchyma by 14 days post-PH (Figure 1G)
. By 30 days post-PH, normal
liver structure is restored by the proliferating small hepatocytes
(data not shown). At this time point the structure of the livers of
retrorsine/PH rats are nearly indistinguishable from that of control
and control/PH rats (data not shown). Newly formed hepatocytes are
arranged in regularly spaced one-cell-thick plates with intervening
sinusoids, and portal tracts and central veins occur in a regular
pattern. Rats in the retrorsine only treatment group have marked
hepatocytomegaly (data not shown) and rare regions of localized
necrosis. Cells with the characteristics of small hepatocyte-like cells
are never observed during liver regeneration in control/PH rats (Figure 1, B, D, F, and H)
. Furthermore, small hepatocyte-like cells are not
observed in the livers of control rats or retrorsine-only rats (data
not shown).
|
|
|
Small hepatocyte-like progenitor cells are not readily identified
in H&E-stained liver sections of retrorsine/PH rats at 1 day post-PH,
but are easily recognized in these liver sections at 3 days post-PH.
These cells are of significantly (P < 0.001)
smaller size (average = 135.4 ± 9.6
µm2) than hepatocytes from control rats
(average = 294.9 ± 15.0 µm2) and
regenerating hepatocytes from control/PH (average = 391.5 ±
23.0 µm2) rats. Small hepatocyte-like
progenitor cells possess small basophilic nuclei, scant and highly
vacuolated cytoplasm, and form clusters that lack sinusoids or well
developed hepatic plates. The small size and highly vacuolated
appearance of these cells persists in the early phase of liver
regeneration from 3 to 10 days post-PH (Figure 1)
. By 14 days post-PH,
the clusters of small hepatocyte-like cells in expanding nodular
aggregates are organized into one- cell-thick plates with
intervening sinusoids, and individual cells lack the vacuolated
appearance that characterize the early cells and are morphologically
indistinguishable from hepatocytes of control rats (Figure 1)
.
At the time of their emergence, small hepatocyte-like cells express
hepatocyte-specific differentiation markers, including albumin and
transferrin. At 5 days post-PH, all observed clusters of small
hepatocytes clearly express albumin (Figure 4A)
, transferrin (Figure 4B)
, and the
hepatocyte-specific antigen recognized by the monoclonal antibody H.4
(Figure 4C)
. In addition, small hepatocyte-like cells possess bile
canaliculi (Figure 4D)
and store glycogen (Figure 4, E and F)
.
Monoclonal antibodies to bile duct markers BD.1, BD.2, and GST-
do
not recognize small hepatocyte-like cells at any point. Ultrastructural
observations confirm the hepatocyte-specific phenotype of these cells
(data not shown). Transmission electron microscopy shows tight
junctions between small hepatocyte-like cells and well-formed bile
canaliculi with microvilli in emerging foci. Individual small
hepatocyte-like cells have abundant mitochondria, glycogen rosettes,
rough endoplasmic reticulum, and peroxisomes (identified based on the
presence of single membrane organelles with crystalline inclusions).
|
Small hepatocyte-like cells express markers of hepatocyte
differentiation as soon as 3 days post-PH in retrorsine/PH rats (Figure 5, C and D)
. It is not possible to identify definitively oval cell
marker-positive small hepatocytes at 3 days post-PH due to the
difficulty with identifying small numbers of these cells in
cryosections at that time. However, at 5 days post-PH when small
hepatocytes are easily identified in frozen sections, a subset of these
cells are decorated with antibodies to oval cell markers OC.2 (Figure 5A)
and, in lesser numbers, OC.5 (Figure 5B)
. At this time point approximately 30% of all small hepatocyte
clusters have OC.2-positive cells and 15% have OC.5-positive cells.
Within each positive cluster, roughly 20% of small hepatocyte-like
cells are positive for OC.2 or OC.5. Examination of serial sections
suggests that these markers are coexpressed on the same subsets of
small hepatocytes and that expression of OC.5 is lost before OC.2. By
comparison, all OC.2-positive and OC.5-positive cells in
retrorsine-only rats express morphological characteristics of oval
cells (data not shown). At no point were small hepatocyte-like cells
positive for OV6. Expression of these oval cell markers in small
hepatocyte-like cells is lost by 7 days post-PH.
|
Retrorsine-exposed rats are able to completely regenerate their
liver mass after PH as evidenced by liver weights (Figure 6A)
and liver/body weight ratios (Figure 6B)
. Regeneration is facilitated by proliferation of small
hepatocyte-like cells that occupy an increasing percentage of the liver
parenchymal area between 5 and 30 days post-PH (Figure 6C)
. The liver
weights of retrorsine/PH rats remain around 3 to 4 g through 14
days post-PH. At 14 days post-PH, small hepatocyte-like cells
proliferate to encompass nearly 50% of the liver parenchyma by area,
yet the liver weight at that time point (average = 3.16 g) is not
significantly different from liver weights (average = 3.02 g)
at 1 day post-PH (P = 0.495). The lack of
increasing liver weights during the early phase of liver regeneration
(014 days post-PH) in retrorsine/PH rats may reflect the continued
loss of megalocytic hepatocytes from the parenchyma through apoptosis.
Apoptotic bodies are present in the livers of all retrorsine/PH rats
during this time period, are infrequently observed in the livers of
retrorsine only rats, and are never observed in the livers of control
and control/PH rats. From 17 to 30 days post-PH, retrorsine/PH livers
gradually increase in size, eventually approximating liver weights of
control/PH rats. At 30 days post-PH, liver weights and liver/body
weight ratios are not significantly different between retrorsine/PH and
control/PH groups (P = 0.982 and
P = 0.294, respectively). By this time, the progeny of
small hepatocyte-like cells occupy virtually the entire parenchyma
in retrorsine/PH rats (87% by area). Control/PH rats nearly double
their liver weight after 3 days and essentially regenerate their liver
mass by 10 days, three times as quickly as retrorsine/PH rats (Figure 6A)
.
|
| Discussion |
|---|
|
|
|---|
Small Hepatocyte-Like Progenitor Cells Express a Distinct Cell Phenotype
The small hepatocyte-like progenitor cells described in
this study share several phenotypic characteristics with fetal
hepatoblasts, oval cells, and fully differentiated hepatocytes, but
differ from each (Table 1)
. Fully
differentiated hepatocytes (and reactive derived megalocytes in
retrorsine/PH rats) express albumin, transferrin, and the antigen
recognized by monoclonal antibody H.4, store glycogen, and possess bile
canaliculi, but do not express oval cell (OV6, OC.2, OC.5, OC.4, OC.10)
and bile duct markers (BD.1, BD.2). These cellular characteristics are
also expressed by fetal hepatoblasts (fetal hepatocytes) of the E18-E20
rat embryo.8,33,42,43
At day 7 post-PH in retrorsine/PH
rats, small hepatocyte-like progenitor cells in expanding clusters
express a cellular phenotype that is indistinguishable from E18-E20
fetal hepatocytes or hepatocytes of the adult liver (Table 1)
. However,
before this time point (at 5 days post-PH), a subset of the small
hepatocyte-like progenitor cells also expresses oval cell markers OC.2
and OC.5 (Figure 5)
. These markers tend to be transiently expressed in
small hepatocyte-like progenitor cells of the smaller clusters,
suggesting that the earliest emerging cells exhibit a distinct (more
primitive?) phenotype compared to their (more mature?) progeny in the
larger cellular aggregates. The expression of OC.2 and OC.5
distinguishes the early small hepatocyte-like progenitor cells from
fully differentiated hepatocytes. Bile duct epithelial cells express
all of the oval cell and bile duct markers examined, whereas oval cells
proliferating in retrorsine-exposed rats express OV6, OC.2, OC.5, and
BD.2 (Table 1)
. Thus, the early small hepatocyte-like progenitor cells
share the expression of OC.2 and OC.5 with bile duct epithelium and
oval cells. However, the expression of multiple hepatocyte-specific
markers and the lack of OV6 positivity clearly distinguish the small
hepatocyte-like progenitor cells from bile duct epithelium and oval
cells. The overall phenotype of the small hepatocyte-like progenitor
cells resembles that expected for a transitional cell type that is
between the bipotential E14 hepatoblast and the E18-E20 fetal
hepatocyte.43
These results combine to suggest that small
hepatocyte-like progenitor cells share several cellular characteristics
with other liver epithelial cell populations, but express an overall
phenotype that differs from each.
|
As is true for other tissues, putative stem-like progenitor cells of the liver have not been identified microscopically and have not been isolated from the liver in pure form, partially reflecting the fact that stem cells and their phenotypic characteristics are largely intuitive concepts.8 Likewise, the ultimate progenitor cell that gives rise to expanding clusters of small hepatocyte-like progenitor cells in regenerating livers of retrorsine-exposed rats has not been definitively identified in the current study. However, the phenotype expressed by the small hepatocyte-like progenitor cells may provide clues as to their cells of origin or to lineage relationships with other cells of the adult liver. Some possible candidates for related cells include (i) a pre-existing population of retrorsine-resistant hepatocytes, (ii) proliferative bile duct epithelial cells (oval cells), or (iii) an unknown (novel) stem-like cell compartment.
The small hepatocyte-like progenitor cells resemble mature hepatocytes
in cellular morphology, express a number of hepatocyte-specific traits,
and emerge from various sites in the lobular hepatic parenchyma. These
observations support the possibility that these cells may arise from a
pre-existing population of retrorsine-resistant hepatocytes. Retrorsine
is metabolized to toxic pyrrolic metabolites through the action of the
P450 enzymes.44,45
Thus, cells that lack expression of the
appropriate P450 enzyme(s) or that express some other protective
mechanism would not be subject to retrorsine-mediated inhibition of
cell replication, and would be available to proliferate in response to
the liver deficit generated by PH. Given the extensive proliferative
capacity of differentiated hepatocytes,14-17
the
existence of a small population of retrorsine-resistant hepatocytes
might account for the regenerative activity observed in
retrorsine-exposed rat livers. However, the expression of oval cell
markers OC.2 and OC.5 by the small hepatocyte-like progenitor cells
early after PH in retrorsine-exposed rats distinguishes these cells
from mature hepatocytes. Although it has not been documented, it is
possible that oval cell antigens could be expressed by proliferative
(and possibly resistant) hepatocytes under the pathophysiological
conditions in the retrorsine-exposed rat liver after PH. Alternatively,
the expression of these antigens by the small hepatocyte-like
progenitor cells might reflect a lineage relationship between these
reactive cells and less differentiated stem-like cells. Typical oval
cells proliferate modestly in the retrorsine model of liver
regeneration,28,46
suggesting that they (and/or their
cells of origin) are resistant to the mito-inhibitory effects of
retrorsine. Previous studies have shown that oval cells are resistant
to a number of different carcinogens that are mitoinhibitory to mature
hepatocytes due to the absence of carcinogen-activated P450
enzymes.47-50
In liver regeneration models that employ
these mitoinhibitory agents, including the modified Solt-Farber
hepatocarcinogenic model40,50-52
and the galactosamine
model of necrotic liver injury,19,39
oval cells
proliferate abundantly to regenerate the hepatic parenchyma. Oval cells
originate in the periportal regions of the liver and are thought to
derive from an undifferentiated stem cell population located in
the periportal parenchyma or from hyperplastic bile
ductules.7,8,53
These cells express multipotential
differentiation capacity33
and give rise to hepatocytes
under appropriate experimental conditions in
vitro54,55
and in vivo.50,51
Thus, the expression of shared phenotypic traits between small
hepatocyte-like progenitor cells and oval cells may reflect their
derivation from a common founder cell (proliferative bile duct
epithelial cell or undifferentiated stem-like cell) or a direct
precursor-product relationship. However, the overall cellular phenotype
expressed by these cell types (Table 1)
and the sublobular site of
their emergence argues for different origins for these cell types. The
last possibility is that the small hepatocyte-like progenitor cells
could represent a novel epithelial progenitor cell population, distinct
from both fully differentiated hepatocytes and oval cells of the adult
rat liver, that has not been recognized in other models of liver
regeneration. The results from the present study strongly suggest that
liver regeneration in retrorsine-exposed rats following PH proceeds
through a novel cellular response that has not been characterized
previously. However, additional studies will be required to discern
cell lineage relationships and identify the ultimate cells of origin of
the small hepatocyte-like progenitor cells in this model system.
Small Hepatocyte-Like Progenitor Cells May Be Related to Regenerative Transplantable Hepatocytes
It is well known from studies of normal liver regeneration after PH that mature hepatocytes expressing a fully differentiated phenotype can replicate enough times to restore hepatocyte numbers and liver mass.10,12,56 Nonetheless, the proliferation capacity of fully differentiated adult hepatocytes has been the subject of intensive investigation in recent years. Using transgenic mouse models of hepatocellular injury and hepatocyte transplantation, several investigators have produced evidence that rodent hepatocytes possess an extensive (possibly unlimited) replicative capacity. In transgenic mice that express the urokinase gene in the liver under the direction of the albumin promoter-enhancer, most hepatocytes are killed by the toxic transgene product, but some residual hepatocytes inactivate the toxic transgene and proliferate, undergoing 10 to 12 cycles of cell division to yield discrete nodular aggregates (clones) that repopulate the liver parenchyma.57 Likewise, when normal (unfractionated) hepatocytes are transplanted into these transgenic mice, nodules of progeny hepatocytes repopulate the damaged liver.15,58 In a similar experimental system, Grompe and colleagues16 have examined the ability of transplanted normal (unfractionated) hepatocytes to repopulate the livers of transgenic mice that are deficient for fumarylacetoacetate hydrolase enzyme activity due to the targeted disruption of exon 5 of the Fah gene.59 These investigators have shown that the transplanted Fah-expressing hepatocytes exhibit a selective growth advantage over host Fah-deficient hepatocytes and effectively repopulate the livers of mutant mice. In these studies, it is estimated that transplanted hepatocytes proliferate through at least 15 cell divisions during repopulation of mutant livers.16 In more recent studies, these same investigators have examined the repopulating and proliferative potential of normal hepatocytes by serial cycles of transplantation, recovery, and transplantation, each time transplanting 103 to 106 cells.17 Full repopulating potential is retained during six consecutive recovery and transplantation cycles, corresponding to at least 86 cell doublings by the transplanted cells since the first transfer, assuming a 15% efficiency of engraftment at each transplant cycle. Based on the results of the serial transplantation experiments, Overturf et al proposed that a subset of transplanted hepatocytes, which they termed the regenerative transplantable hepatocyte (RTH), exhibit high repopulating capacity.17 It is intriguing to speculate that cells akin to the small hepatocyte-like progenitor cells identified in the present study may be responsible for repopulation of the livers of PA-treated27 and retrorsine-exposed28 rats following transplantation of unfractionated hepatocytes, and that these cells may be the RTH proposed by Grompe.17 The progeny of proliferative small hepatocyte-like progenitor cells in retrorsine/PH rats form expanding nodular aggregates of cells that eventually replace megalocytes (compromised hepatocytes) and remodel to form parenchyma with normal structure in a manner indistinguishable from that observed in these transgenic mouse models.15,17,57,58
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by grants CA29323 (to J. W. G.) and CA78434 (to W. B. C.) from the National Institutes of Health.
Preliminary findings were presented at the Experimental Biology 1999 Conference and published in abstract form (Gordon GJ, Coleman WB, Hixson DC, Grisham JW: Cellular responses during liver regeneration after partial hepatectomy in rats with retrorsine-induced hepatocellular injury. FASEB J 1999, 13:A189; Gordon GJ, Coleman WB, Grisham JW: Transplantation of WB-F344 stem-like cells into rats following retrorsine-induced hepatocellular injury. FASEB J 1999, 13:A160).
Accepted for publication October 26, 1999.
| References |
|---|
|
|
|---|
-fetoprotein messenger RNA expression in the retrorsine model for hepatocyte transplantation. Cancer Res 1998, 58:5825-5834This article has been cited by other articles:
![]() |
X.-Z. Wu Origin of Cancer Stem Cells: The Role of Self-Renewal and Differentiation Ann. Surg. Oncol., February 1, 2008; 15(2): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Herrera, S. Bruno, S. Buttiglieri, C. Tetta, S. Gatti, M. C. Deregibus, B. Bussolati, and G. Camussi Isolation and Characterization of a Stem Cell Population from Adult Human Liver Stem Cells, December 1, 2006; 24(12): 2840 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Simper-Ronan, K. Brilliant, D. Flanagan, M. Carreiro, H. Callanan, E. Sabo, and D. C. Hixson Cholangiocyte marker-positive and -negative fetal liver cells differ significantly in their ability to regenerate the livers of adult rats exposed to retrorsine Development, November 1, 2006; 133(21): 4269 - 4279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Walkup and D. A. Gerber Hepatic Stem Cells: In Search of Stem Cells, August 1, 2006; 24(8): 1833 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chien, B. L. Yen, F.-K. Lee, T.-H. Lai, Y.-C. Chen, S.-H. Chan, and H.-I Huang In Vitro Differentiation of Human Placenta-Derived Multipotent Cells into Hepatocyte-Like Cells Stem Cells, July 1, 2006; 24(7): 1759 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Li, J. Su, Y.-C. Yao, X.-R. Tao, Y.-B. Yan, H.-Y. Yu, X.-M. Wang, J.-X. Li, Y.-J. Yang, J. T.Y. Lau, et al. Isolation and Characterization of Bipotent Liver Progenitor Cells from Adult Mouse Stem Cells, February 1, 2006; 24(2): 322 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masson, D. J. Harrison, J. N. Plevris, and P. N. Newsome Potential of Hematopoietic Stem Cell Therapy in Hepatology: A Critical Review Stem Cells, November 1, 2004; 22(6): 897 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Jensen, E. I. Jauho, E. Santoni-Rugiu, U. Holmskov, B. Teisner, N. Tygstrup, and H. C. Bisgaard Transit-Amplifying Ductular (Oval) Cells and Their Hepatocytic Progeny Are Characterized by a Novel and Distinctive Expression of Delta-Like Protein/Preadipocyte Factor 1/Fetal Antigen 1 Am. J. Pathol., April 1, 2004; 164(4): 1347 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
|